Work

Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: New England Journal of Medicine

DOI: 10.1056/nejmoa2500969

Authors: Sean Wharton, Ildiko Lingvay, Pawel Bogdanski, Ruben Duque do Vale, Stephan Jacob, Tobias Karlsson, Chaithra Shaji, Domenica Rubino, W. Timothy Garvey

Institutions: University of Toronto, York University, McMaster University, The University of Texas Southwestern Medical Center, Poznan University of Medical Sciences, Novo Nordisk (Denmark), Novo Nordisk (India), Washington Center for Weight Management and Research, University of Alabama at Birmingham

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk

OpenAlex ID: W4414160143

FWCI: 65.53

Cites: 12

Cited by: 137

Related to: 10